American Board of Medical Laboratory Immunology (ABMLI)
The ABLMI was established in 1975 to test the expertise of immunologists. Board-certified immunologists are adjudged capable to direct laboratories engaged in the practice of medical laboratory immunology. Certification by the ABMLI is the highest credential available to practicing medical laboratory immunologists.
ABMLI certification is recognized by federal and state governmental agencies as a significant component toward meeting licensure requirements to direct laboratories engaged in the immunological diagnosis of human disease. It is recognized under the Clinical Laboratory Improvement Amendments of 1988 final rule and in 11 of 12 states that require licensure: Florida, Georgia, Hawaii, Louisiana, Montana, Nevada, New York, North Dakota, Rhode Island, Tennessee, and West Virginia.
The ABMLI will phase out its certification exam; the last exam will be offered in August 2017. The final application deadline was June 1, 2016. Applications are no longer accepted. The ABMLI will continue to serve its Diplomates through recertification, maintaining an active roll of Diplomates and verification of certification status. The Centers for Medicare and Medicaid Services has confirmed that it will continue to recognize ABMLI certification as a personnel requirement for high-complexity laboratory directors even though the exam will no longer be offered.
For complete information, click on the link below: